Characterization of antimicrobial resistance among Proteus mirabilis isolates from catheter-associated urinary tract infections and non-catheter-associated urinary tract infections in Egypt

被引:0
作者
Hassuna, Noha A. [1 ]
Kotb, Dalia N. [1 ]
Lami, Marina [1 ]
Abdelrahim, Soha S. [1 ]
机构
[1] Minia Univ, Fac Med, Dept Med Microbiol & Immunol, El Minia 61511, Egypt
关键词
Proteus mirabilis; Catheter-associated; Urinary tract infection; Multidrug resistance; Beta-lactamases; Integrons; MOLECULAR CHARACTERIZATION; ESCHERICHIA-COLI; INTEGRONS; STRAINS; PCR;
D O I
10.1186/s12879-025-11118-8
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
BackgroundRecent worldwide reports of increased numbers of multidrug-resistant (MDR) Proteus mirabilis (P. mirabilis) isolates, particularly those producing extended-spectrum beta-lactamases (ESBLs), are alarming. P. mirabilis is a common causative agent of complicated urinary tract infections (UTIs), particularly in patients with long-term urinary catheterization. This study aimed to assess the prevalence, antibiotic resistance patterns, and determinants of P. mirabilis among catheter-associated UTIs (CAUTI) and non-catheter-associated UTIs (non-CAUTI).MethodsOne hundred and three Proteus strains isolated from 613 UTI patients in Minia, Egypt, were examined for antibiotic resistance patterns, ESBL production, and sulphonamide resistance phenotypically. Class 1 and 2 integrons, ESBL, and sul resistance genes were detected by Polymerase chain reaction (PCR), followed by molecular typing of ESBL-producing isolates from catheterized UTI patients using ERIC-PCR.ResultsProteus isolates were detected in 20% of the UTIs, with a higher rate among inpatients (27.3%) compared to outpatients (10.6%). Proteus was more significantly isolated from catheterized UTI patients (28.2%, 55/195) than from non-catheterized patients (14.9%, 48/321). Of the 103 Proteus isolates, 99 (96.1%) were identified as P. mirabilis. High resistance was observed against trimethoprim/sulfamethoxazole (SXT) (80.6%), amoxicillin-clavulanic (AMC) (57.3%), ceftazidime (55.3%), and imipenem (46.6%) antibiotics. Significantly higher resistance rates were observed among Proteus isolates from inpatients and catheterized patients. Of the 103 Proteus strains, 81 (78.6%) were MDR, with 70.9% of the isolates from catheterized patients. About 74.6% of the isolates from inpatients were MDR. Sul genes were detected in 77 isolates (74.7%). The frequency of ESBL-producing Proteus isolates was 37.9% which was significantly higher in catheterized patients with increasing dissemination of blaTEM genes and blaCTX-M genes. Int1 and Int2 genes were detected in 92.2% and 68.9% of isolates, respectively. ERIC-PCR revealed moderate similarity (65%) between ESBL-producing Proteus isolates from catheterized patients.ConclusionThe high frequency of MDR P. mirabilis strains isolated from UTIs in Egypt, particularly among catheterized patients, is a major concern, especially with disseminating class 1 and 2 integrons among isolates. The study also highlights the decreased susceptibility to sulphonamides, 3rd generation cephalosporins, and imipenem, commonly used to treat UTIs. Increased dissemination of ESBL-producing Proteus isolates among CAUTIs complicates their treatments. This important pathogen deserves more attention in the future for a better understanding of resistance mechanisms and the dissemination potential of resistant strains.
引用
收藏
页数:11
相关论文
共 48 条
[1]  
Adeolu M., Genome-based phylogeny and taxonomy of the Enterobacteriales: proposal for enterobacterales ord. nov. divided into the families Enterobacteriaceae, Erwiniaceae fam. nov., Pectobacteriaceae fam. nov., Yersiniaceae fam. nov., Hafniaceae fam. nov., Morgane, Int. J. Syst
[2]   The impact of production of extended-spectrum β-lactamases on the 28-day mortality rate of patients with Proteus mirabilis bacteremia in Korea [J].
Ahn, Jin Young ;
Ann, Hea Won ;
Jeon, Yongduk ;
Ahn, Mi Young ;
Oh, Dong Hyun ;
Kim, Yong Chan ;
Kim, Eun Jin ;
Song, Je Eun ;
Jung, In Young ;
Kim, Moo Hyun ;
Jeong, Wooyoung ;
Ku, Nam Su ;
Jeong, Su Jin ;
Choi, Jun Yong ;
Yong, Dongeun ;
Song, Young Goo ;
Kim, June Myung .
BMC INFECTIOUS DISEASES, 2017, 17
[3]  
Al-obaidi S., 2023, The Egyptian Journal of Hospital Medicine, V90, P716, DOI [10.21608/ejhm.2023.279843, DOI 10.21608/EJHM.2023.279843]
[4]   Molecular screening of antibiotic-resistant determinants among multidrug-resistant clinical isolates of Proteus mirabilis from SouthWest Nigeria [J].
Alabi, Olumuyiwa Samuel ;
Mendonca, Nuno ;
Adeleke, Olufemi Ezekiel ;
da Silva, Gabriela Jorge .
AFRICAN HEALTH SCIENCES, 2017, 17 (02) :356-365
[5]  
Ali Dalia G., 2023, Novel Research in Microbiology Journal, V7, P1966, DOI 10.21608/nrmj.2023.300633
[6]   Sulfonamide Resistance Genes (sul) M in Extended Spectrum Beta Lactamase (ESBL) and Non-ESBL Producing Escherichia coli Isolated From Iranian Hospitals [J].
Arabi, Hadis ;
Pakzad, Iraj ;
Nasrollahi, Ayat ;
Hosainzadegan, Hasan ;
Jalilian, Farid Azizi ;
Taherikalani, Morovvat ;
Samadi, Naser ;
Sefidan, Allireza Monadi .
JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2015, 8 (07)
[7]  
Centers for Disease Control and Prevention, 2025, URINARY TRACT INFECT
[8]  
CLSI, 2023, Performance standards for antimicrobial susceptibility testingCLSI supplement M100
[9]   Bacterial species and antimicrobial resistance differ between catheter and non-catheter-associated urinary tract infections: Data from a national surveillance network [J].
D'Incau, Stephanie ;
Atkinson, Andrew ;
Leitner, Lorenz ;
Kronenberg, Andreas ;
Kessler, Thomas M. ;
Marschall, Jonas .
ANTIMICROBIAL STEWARDSHIP & HEALTHCARE EPIDEMIOLOGY, 2023, 3 (01)
[10]  
Dashti AA, 2009, KUWAIT MED J, V41, P117